000 02439 a2200685 4500
005 20250516231301.0
264 0 _c20151103
008 201511s 0 0 eng d
022 _a1573-904X
024 7 _a10.1007/s11095-014-1501-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKang, Jeong Yeon
245 0 0 _aPharmacokinetics, antitumor and cardioprotective effects of liposome-encapsulated phenylaminoethyl selenide in human prostate cancer rodent models.
_h[electronic resource]
260 _bPharmaceutical research
_cMar 2015
300 _a852-62 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aAntioxidants
_xadministration & dosage
650 0 4 _aArea Under Curve
650 0 4 _aCardiomegaly
_xchemically induced
650 0 4 _aCell Line, Tumor
650 0 4 _aChemistry, Pharmaceutical
650 0 4 _aChromatography, Liquid
650 0 4 _aDisease Models, Animal
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDoxorubicin
650 0 4 _aEthylamines
_xadministration & dosage
650 0 4 _aGene Expression Regulation
_xdrug effects
650 0 4 _aHalf-Life
650 0 4 _aHumans
650 0 4 _aInjections, Intravenous
650 0 4 _aLiposomes
650 0 4 _aMale
650 0 4 _aMass Spectrometry
650 0 4 _aMetabolic Clearance Rate
650 0 4 _aMice, Nude
650 0 4 _aMyocytes, Cardiac
_xdrug effects
650 0 4 _aOrganoselenium Compounds
_xadministration & dosage
650 0 4 _aOxidative Stress
_xdrug effects
650 0 4 _aProstatic Neoplasms
_xdrug therapy
650 0 4 _aRats, Inbred F344
650 0 4 _aReactive Oxygen Species
_xmetabolism
650 0 4 _aTechnology, Pharmaceutical
_xmethods
650 0 4 _aTumor Burden
_xdrug effects
650 0 4 _aXenograft Model Antitumor Assays
700 1 _aEggert, Mathew
700 1 _aMouli, Shravanthi
700 1 _aAljuffali, Ibrahim
700 1 _aFu, Xiaoyu
700 1 _aNie, Ben
700 1 _aSheil, Amy
700 1 _aWaddey, Kendall
700 1 _aOldham, Charlie D
700 1 _aMay, Sheldon W
700 1 _aAmin, Rajesh
700 1 _aArnold, Robert D
773 0 _tPharmaceutical research
_gvol. 32
_gno. 3
_gp. 852-62
856 4 0 _uhttps://doi.org/10.1007/s11095-014-1501-5
_zAvailable from publisher's website
999 _c24131758
_d24131758